Filter

  • Advanced Filters:

  • to
  • Specific Data Sources:

    All Edit

    Select All  |  Select None

Reset filters

DeepDyve - Search, Rent, Read
The easiest way for you to get scholarly articles:

  • Millions of articles from over 6,000 authoritative journals.
  • Get any 40 rentable articles for just $40 a month.
  • Read rented articles for an entire year.
  • Unused rentals get rolled over.

Bookmark

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer

Liu, Zhenxiong; Wang, Xin; Lu, Yuanyuan; Han, Shuang; Zhang, Faming; Zhai, Huihong; Lei, Ting; Liang, Jie; Wang, Jun; Wu, Kaichun; Fan, Daiming
Carcinogenesis , Volume 29 (6): 1219 Oxford University PressJun 1, 2008

Preview Only

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer

Abstract

Abstract To explore the proteins regulated by cyclooxygenase-2 (COX-2) in gastric cancer, the expression plasmid of COX-2siRNA was constructed and transfected into gastric cancer cell line SGC7901. Then, two-dimensional electrophoresis and the PDQuest software analysis were applied to discover the differentially expressed proteins. The differential protein spots were analyzed by matrix-assisted laser desorption/ionization time of flight mass spectrometry. Fourteen differentially expressed proteins between the two cell lines were identified. 15-Hydroxyprostaglandin dehydrogenase NAD + (15-PGDH), a key enzyme in prostaglandin degradation, was identified as an upregulated protein in SGC7901 cells transfected with the COX-2siRNA plasmid. To further explore whether the 15-PGDH is regulated by COX-2, western blotting and immunocytochemical assay were performed to detect the expression of 15-PGDH in different cell lines with different expression level of COX-2. The results showed that the expression of 15-PGDH was upregulated (128.57%) as COX-2 was suppressed by small interfering RNA and downregulated (51.72%) as COX-2 was enhanced by COX-2 cDNA transfection in gastric cancer cells. In tissue specimens with gastric cancer, there was a decreased expression of 15-PGDH and an increased expression of COX-2 simultaneously. A significantly negative correlation of 15-PGDH expression was found to COX-2 level, tumor differentiation, tumor, lymph node, metastasis (TNM) staging and lymph node metastasis of gastric cancer. All the results suggest that 15-PGDH is downregulated by COX-2 in human gastric cancer and may contribute to the carcinogenesis and development of human gastric cancer in combination with COX-2. Abbreviations: Abbreviations COX-2 cyclooxygenase-2 DTT dithiothreitol 2-DE two-dimensional electrophoresis IEF isoelectric focusing IPG immobilized pH gradient MALDI-TOF MS matrix-assisted laser desorption/ionization time of flight mass spectrometry 15-PGDH 15-hydroxyprostaglandin dehydrogenase NAD + siRNA small interfering RNA TNM tumor, lymph node, metastasis © The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Loading next page...
1 Page

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/oxford-university-press/expression-of-15-pgdh-is-downregulated-by-cox-2-in-gastric-cancer-d5kpvD0bIw
Title
Expression of 15-PGDH is downregulated by COX-2 in gastric cancer
Author(s)
Liu, Zhenxiong; Wang, Xin; Lu, Yuanyuan; Han, Shuang; Zhang, Faming; Zhai, Huihong; Lei, Ting; Liang, Jie; Wang, Jun; Wu, Kaichun; Fan, Daiming
Journal
Carcinogenesis , Volume 29 (6): 1219 Oxford University Press – Jun 1, 2008
Publisher
Oxford University Press
Copyright
Copyright © 2010 Oxford University Press
ISSN
0143-3334
eISSN
1460-2180
D.O.I.
10.1093/carcin/bgm297
Publisher site
Get PDF